Stocktwits on MSN2d
Allurion Stock Tumbles Over Disappointing Quarterly Earnings, Revenue Guidance – But Retail’s Not ConcernedShares of Allurion Technologies, Inc. (ALUR) tumbled nearly 11% on Wednesday morning after the company’s fourth-quarter (Q4) ...
Microcap Allurion Technologies (NYSE:ALUR) surged ~31% in after-hours trading Thursday after posting preliminary data on ...
Roth MKM keeps a Buy rating and $16 price target on Allurion Technologies (ALUR) after its initial results from Allurion Program-GLP-1 combo.
The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss, the Allurion ...
The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including ...
The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-lessTM gastric balloon for weight loss with the ...
Reports Q4 revenue $5.6M, compared to $8.2M for the same period in 2023. The year-over-year decrease in revenue was primarily due to the ...
Microcap Allurion Technologies (NYSE:ALUR) surged ~31% in after-hours trading Thursday after posting preliminary data on weight loss associated with its gastric balloon in combination with Novo ...
NATICK, Mass., March 04, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback